HomePSTV • NASDAQ
add
Plus Therapeutics Inc
Nakaraang pagsara
$1.28
Sakop ng araw
$1.23 - $1.28
Sakop ng taon
$1.12 - $2.67
Market cap
6.85M USD
Average na Volume
98.39K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 1.46M | 17.42% |
Gastos sa pagpapatakbo | 2.40M | 19.97% |
Net na kita | -2.87M | 10.72% |
Net profit margin | -197.39 | 23.96% |
Kita sa bawat share | -0.37 | 63.00% |
EBITDA | -3.60M | -16.43% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 4.79M | -56.50% |
Kabuuang asset | 6.98M | -47.45% |
Kabuuang sagutin | 12.15M | 14.04% |
Kabuuang equity | -5.17M | — |
Natitirang share | 5.90M | — |
Presyo para makapag-book | -1.45 | — |
Return on assets | -104.43% | — |
Return on capital | 318.44% | — |
Cash Flow
Net change in cash
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -2.87M | 10.72% |
Cash mula sa mga operasyon | -3.68M | -53.40% |
Cash mula sa pag-invest | -9.00K | 10.00% |
Cash mula sa financing | 0.00 | -100.00% |
Net change in cash | -3.69M | -3,423.42% |
Malayang cash flow | -8.35M | -525.46% |
Tungkol
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for adults and children with rare and difficult-to-treat cancers. The company is headquartered in Austin, Texas, United States. Wikipedia
Itinatag
1996
Headquarters
Website
Mga Empleyado
20
